Literature DB >> 4011462

Coronary aneurysms in Kawasaki disease: follow-up observation by two-dimensional echocardiography.

M Yanagisawa, S Yano, H Shiraishi, Y Nakajima, T Fujimoto, K Itoh.   

Abstract

The development and regression of the coronary aneurysms in Kawasaki disease was studied with serial two-dimensional echocardiographic (2D echo) examinations. The diameter of the aneurysms at the proximal portions of the left coronary artery was measured on the 2D echo images in ten patients with Kawasaki disease, in whom left coronary aneurysms were found at the acute stage of the illness, and followed by 2D echo for longer than eight months. It was found that coronary aneurysms usually developed during the second week of the illness, reached maximal size at 3-8 weeks, and regressed gradually thereafter. Small aneurysms disappeared in several months, and those of intermediate size regressed in one to two years. Large aneurysms may remain for many years. Mural thrombi within the aneurysms were detected with 2D echo in three patients. They decreased in echodensity and eventually disappeared echographically.

Entities:  

Mesh:

Year:  1985        PMID: 4011462     DOI: 10.1007/BF02265402

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  18 in total

1.  Mucocutaneous lymph node syndrome in the United States.

Authors:  M E Melish; R M Hicks; E J Larson
Journal:  Am J Dis Child       Date:  1976-06

2.  Manifestations of Kawasaki disease in New England outbreak of 1980.

Authors:  R H Meade; L Brandt
Journal:  J Pediatr       Date:  1982-04       Impact factor: 4.406

3.  Ultrasonography of mucocutaneous lymph node syndrome.

Authors:  M S Vangrov; H Kangarloo; T G Di Sessa; J B Isabel-Jones; H Heins
Journal:  Radiology       Date:  1981-04       Impact factor: 11.105

4.  [Two-dimensional echocardiographic study of coronary artery lesion in Kawasaki disease: a new approach to visualize the right coronary artery].

Authors:  E Ichinose; Y Eto; T Takechi; F Yoshioka; H Kato
Journal:  J Cardiogr       Date:  1982-03

5.  Kawasaki disease: effect of treatment on coronary artery involvement.

Authors:  H Kato; S Koike; T Yokoyama
Journal:  Pediatrics       Date:  1979-02       Impact factor: 7.124

6.  [Two-dimensional echocardiography of coronary artery in Kawasaki disease (MCLS): detection, changes in acute phase, and follow-up observation of the aneurysm (author's transl)].

Authors:  O Hirose; H Misawa; Y Kijima; O Yamada; Y Arakaki; Y Kajino; Y Ryujin; T Kowata; S Echigo; T Kamiya
Journal:  J Cardiogr       Date:  1981-03

7.  Cross-sectional echocardiographic diagnosis of coronary artery aneurysms in patients with the mucocutaneous lymph node syndrome.

Authors:  J Yoshikawa; K Yanagihara; T Owaki; H Kato; Y Takagi; F Okumachi; T Fukaya; Y Tomita; K Baba
Journal:  Circulation       Date:  1979-01       Impact factor: 29.690

8.  Pathology of the heart in Kawasaki disease.

Authors:  H Fujiwara; Y Hamashima
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

9.  Mucocutaneous lymph node syndrome. A cross-sectional echocardiographic diagnosis of coronary aneurysms.

Authors:  H Yoshida; T Funabashi; S Nakaya; N Taniguchi
Journal:  Am J Dis Child       Date:  1979-12

10.  An epidemic of Kawasaki syndrome in Hawaii.

Authors:  A G Dean; M E Melish; R Hicks; N E Palumbo
Journal:  J Pediatr       Date:  1982-04       Impact factor: 4.406

View more
  3 in total

1.  Diameter of coronary arteries in infancy.

Authors:  S Musumeci; G Giordano; A D'Agata
Journal:  Eur J Pediatr       Date:  1989-11       Impact factor: 3.183

2.  Recurrent Kawasaki disease.

Authors:  T A Vargo; J C Huhta; W H Moore; D A Person; M S Edwards
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

3.  Transthoracic ultrasonic visualisation of coronary aneurysm, stenosis, and occlusion in Kawasaki disease.

Authors:  S Hiraishi; H Misawa; N Takeda; Y Horiguchi; N Fujino; N Ogawa; H Hirota
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.